These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 19912230)

  • 1. The impact of GPCR structures on pharmacology and structure-based drug design.
    Congreve M; Marshall F
    Br J Pharmacol; 2010 Mar; 159(5):986-96. PubMed ID: 19912230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of GPCR structures in drug design.
    Congreve M; Langmead C; Marshall FH
    Adv Pharmacol; 2011; 62():1-36. PubMed ID: 21907905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection.
    Saikia S; Bordoloi M; Sarmah R
    Curr Drug Targets; 2019; 20(5):522-539. PubMed ID: 30394207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
    Bhunia SS; Saxena AK
    Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPCR crystal structures: Medicinal chemistry in the pocket.
    Shonberg J; Kling RC; Gmeiner P; Löber S
    Bioorg Med Chem; 2015 Jul; 23(14):3880-906. PubMed ID: 25638496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein-coupled receptors--recent advances.
    Latek D; Modzelewska A; Trzaskowski B; Palczewski K; Filipek S
    Acta Biochim Pol; 2012; 59(4):515-29. PubMed ID: 23251911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists.
    Hagiwara Y; Ohno K; Kamohara M; Takasaki J; Watanabe T; Fukunishi Y; Nakamura H; Orita M
    Expert Opin Drug Discov; 2013 Aug; 8(8):951-64. PubMed ID: 23682717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of Class B GPCRs: new horizons for drug discovery.
    Bortolato A; Doré AS; Hollenstein K; Tehan BG; Mason JS; Marshall FH
    Br J Pharmacol; 2014 Jul; 171(13):3132-45. PubMed ID: 24628305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of G protein-coupled receptors as targets in drug discovery.
    Lundstrom K
    IDrugs; 2005 Nov; 8(11):909-13. PubMed ID: 16254784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014.
    Heifetz A; Schertler GF; Seifert R; Tate CG; Sexton PM; Gurevich VV; Fourmy D; Cherezov V; Marshall FH; Storer RI; Moraes I; Tikhonova IG; Tautermann CS; Hunt P; Ceska T; Hodgson S; Bodkin MJ; Singh S; Law RJ; Biggin PC
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Aug; 388(8):883-903. PubMed ID: 25772061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for the Rational Design of Allosteric Modulators of Class C GPCRs.
    Christopher JA; Doré AS; Tehan BG
    Curr Top Med Chem; 2017; 17(1):71-78. PubMed ID: 27448651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structures of class B G protein-coupled receptors: prospects for drug discovery.
    Hausch F
    Angew Chem Int Ed Engl; 2013 Dec; 52(49):12783-5. PubMed ID: 24127232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New G-protein-coupled receptor crystal structures: insights and limitations.
    Kobilka B; Schertler GF
    Trends Pharmacol Sci; 2008 Feb; 29(2):79-83. PubMed ID: 18194818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights from structural biology into the druggability of G protein-coupled receptors.
    Mason JS; Bortolato A; Congreve M; Marshall FH
    Trends Pharmacol Sci; 2012 May; 33(5):249-60. PubMed ID: 22465153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of G protein-coupled receptor crystallography for drug discovery.
    Salon JA; Lodowski DT; Palczewski K
    Pharmacol Rev; 2011 Dec; 63(4):901-37. PubMed ID: 21969326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From purified GPCRs to drug discovery: the promise of protein-based methodologies.
    Alkhalfioui F; Magnin T; Wagner R
    Curr Opin Pharmacol; 2009 Oct; 9(5):629-35. PubMed ID: 19443270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New paradigms in GPCR drug discovery.
    Jacobson KA
    Biochem Pharmacol; 2015 Dec; 98(4):541-55. PubMed ID: 26265138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The year in G protein-coupled receptor research.
    Millar RP; Newton CL
    Mol Endocrinol; 2010 Jan; 24(1):261-74. PubMed ID: 20019124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.